US Patent Issued to KAOHSIUNG MEDICAL UNIVERSITY on Sept. 1 for "Anti-CXCR2 antibodies and uses thereof" (Taiwanese Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,092, issued on Sept. 1, was assigned to KAOHSIUNG MEDICAL UNIVERSITY (Kaohsiung City, Taiwan).

"Anti-CXCR2 antibodies and uses thereof" was invented by Li-Tzong Chen (Kaohsiung City, Taiwan), Wen-Chun Hung (Miaoli County, Taiwan) and Ko-Jiunn Liu (Miaoli County, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Anti-CXCR2 antibodies that recognize CXCR2 and inhibit the activity of CXCR2, and the use of the anti-CXCR2 antibodies in the treatment of pancreatic cancer and leukemia."

The patent was filed on April 25, 2022, under Application No. 18/549,165.

*For further information, including images, charts and tables, please visit: http://patft.us...